science1 distinct publisher
NewBiologix will engineer a Duchenne producer cell line before the vector reaches the clinic
A Swiss platform company will build and characterize a research cell bank for a Turkish micro-dystrophin candidate, an early manufacturing commitment the announcement backs with design intent rather than yield data.
Publishers:genengnews.com
Reality
- Evidence32
- Adoption14
- Hype gap+28
- Incentives78